Journal of thrombosis and haemostasis : JTH · 2026
Immunogenic risk assessment of porcine, bovine, and ovine heparins for diversifying the global heparin supply.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Bin, Bu Changkai, Geng Yuxin, An Zizhe, Chen Lexin, Zhang Qunye, Zhang Fuming, Shi Deling, Chi Lianli
Аннотация
BACKGROUND: The global heparin supply relies heavily on porcine mucosa, prompting renewed interest in ruminant-derived alternatives. However, concerns regarding heparin-induced thrombocytopenia remain a major barrier to their clinical reintroduction.
OBJECTIVES: To systematically evaluate the platelet factor 4 (PF4)-dependent immunogenic potential of porcine mucosal heparin, bovine lung heparin, and ovine mucosal heparin, as well as their low-molecular-weight heparin (LMWH) derivatives, and to delineate the structural features governing these interactions.
METHODS: Size-exclusion chromatography and a competitive ELISA established in this study were used to monitor PF4-heparin complex stoichiometry and antibody recognition. Flow cytometry quantified functional heparin-induced platelet activation (CD62P/CD63 expression). PF4 affinity chromatography-hydrophilic interaction liquid chromatography-mass spectrometry and molecular docking characterized high-affinity glycan features and evaluated sulfation patterns in stabilizing PF4-heparin interactions.
RESULTS: Under equipotent dosing conditions, PF4 complex formation, antibody recognition, and platelet activation followed the order bovine lung heparin > ovine mucosal heparin > porcine mucosal heparin. Differences among heparins were largely explained by molecular weight-dependent stoichiometry. In contrast, source-dependent differences among LMWHs persisted after potency normalization, with bovine LMWH forming significantly more PF4 complexes and triggering the most robust platelet activation. Affinity profiling identified degree of polymerization 6-degree of polymerization 8 (dp6-dp8) as minimal PF4-binding units and revealed that increased sulfation and reduced N-acetylation enhance PF4 affinity. Molecular docking confirmed that N-sulfation stabilizes PF4-heparin interactions.
CONCLUSION: Heparins derived from different animal sources exhibit distinct PF4-binding properties and immunogenic profiles. These findings provide mechanistic insight into species-dependent heparin-induced thrombocytopenia risk-driven by stoichiometry in heparin and fine structural features in LMWH-and support diversification of the global heparin supply.
OBJECTIVES: To systematically evaluate the platelet factor 4 (PF4)-dependent immunogenic potential of porcine mucosal heparin, bovine lung heparin, and ovine mucosal heparin, as well as their low-molecular-weight heparin (LMWH) derivatives, and to delineate the structural features governing these interactions.
METHODS: Size-exclusion chromatography and a competitive ELISA established in this study were used to monitor PF4-heparin complex stoichiometry and antibody recognition. Flow cytometry quantified functional heparin-induced platelet activation (CD62P/CD63 expression). PF4 affinity chromatography-hydrophilic interaction liquid chromatography-mass spectrometry and molecular docking characterized high-affinity glycan features and evaluated sulfation patterns in stabilizing PF4-heparin interactions.
RESULTS: Under equipotent dosing conditions, PF4 complex formation, antibody recognition, and platelet activation followed the order bovine lung heparin > ovine mucosal heparin > porcine mucosal heparin. Differences among heparins were largely explained by molecular weight-dependent stoichiometry. In contrast, source-dependent differences among LMWHs persisted after potency normalization, with bovine LMWH forming significantly more PF4 complexes and triggering the most robust platelet activation. Affinity profiling identified degree of polymerization 6-degree of polymerization 8 (dp6-dp8) as minimal PF4-binding units and revealed that increased sulfation and reduced N-acetylation enhance PF4 affinity. Molecular docking confirmed that N-sulfation stabilizes PF4-heparin interactions.
CONCLUSION: Heparins derived from different animal sources exhibit distinct PF4-binding properties and immunogenic profiles. These findings provide mechanistic insight into species-dependent heparin-induced thrombocytopenia risk-driven by stoichiometry in heparin and fine structural features in LMWH-and support diversification of the global heparin supply.